WASHINGTON, D.C. 20549

(Name of Issuer)

(Title of Series of Securities)

(CUSIP number)

(Name, address and telephone number of person authorized to
receive notices and communications)

(Date of event which requires filing of this statement)

 

 

CUSIP No.		001282 20 1	13D		Page 2 of 6 Pages

(1)     Includes 13,609 Series B shares subject to options that are presently exercisable or that become exercisable within 60 days.

Item 1. Security and Issuer

     This statement on Schedule 13D (this “Statement”) relates to Series B Common Stock, par value $0.01 per share (the “Common Stock”), of A.H. Belo Corporation, a Delaware corporation (the “Issuer”). The address of the principal executive office of the Issuer is P.O. Box 224866, Dallas, Texas, 75222-4866.

Item 2 — Identity and Background

     a) This Statement is filed on behalf of Dealey D. Herndon (the “Reporting Person”).

     b) The address of the principal business and principal office for the Reporting Person is P.O. Box 224866, Dallas, Texas, 75222-4866.

     c) The Reporting Person is a Director of the Issuer, which is a newspaper publishing company. The business address of the Issuer is A.H. Belo Corporation, 400 South Record Street, Dallas, TX 75202.

     d) & e) During the last five years, the Reporting Person (i) has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) and (ii) has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

     f) The Reporting Person is a citizen of the United States.

Item 3. Source and Amount of Funds or Other Consideration

On February 8, 2008, to effect the spin-off of the Issuer from Belo Corp. (BLC), BLC distributed all of the outstanding shares of Series B Common Stock of the Issuer to holders of BLC Series B Common Stock of record as of the close of business on January 25, 2008. With respect to Series B Common Stock, 0.20 shares of the Issuer was distributed for each share of BLC. In addition, for each stock option held by the Reporting Person on the record date for the spin-off, the Reporting Person received new stock options of the Issuer for 20% of the number of shares subject to the BLC options and for each restricted stock unit held by the Reporting Person prior to the spin-off, the Reporting Person received 0.20 Issuer restricted stock units. Thereafter, the Reporting Person acquired beneficial ownership of shares that are subject to these awards upon the vesting of these awards. No funds were expended in connection with the foregoing acquisition.

Item 4. Purpose of Transaction

     The Reporting Person intends to review her investment in the Issuer on a continuing basis and may, at any time, consistent with the Reporting Person’s obligations under the federal securities laws, determine to increase or decrease her ownership of shares of the Issuer’s Series B common stock through purchases or sales in the open market or in privately-negotiated transactions. The Reporting Person’s review of her investment in the Issuer will depend on various factors, including the Issuer’s business prospects, other developments concerning the Issuer, general economic conditions, financial and stock market conditions, the Reporting Person’s personal financial situation, need for, and availability of capital, and any other facts and circumstances which may become known to the Reporting Person regarding her investment in the Issuer. At the time of this filing, the Reporting Person has no plans to purchase additional shares of common stock in the open market in the immediate future. However, the Reporting Person may engage in privately-negotiated transactions in the future, may from time-to-time acquire additional shares of common stock under various employee benefit and compensation arrangements of the Issuer, and reserves her right to reevaluate her investment in the Issuer and to purchase additional shares in the open market or otherwise.

     Except as may occur in the ordinary course of business of the Issuer, the Reporting Person has no present plans or proposals which relate to or would result in (i) an extraordinary corporate transaction, such as a merger, reorganization, or liquidation, involving the Issuer or any of its subsidiaries, (ii) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries, (iii) any change in the board of directors or executive management of the Issuer or any of its subsidiaries, (iv) any material change in the present capitalization or dividend policy of the Issuer, (v) any other material change in the Issuer’s business or corporate structure, (vi) changes in the Issuer’s Certificate of Incorporation or bylaws or other actions that may impede the acquisition of control of the Issuer by any person, (vii) a series of securities of the Issuer being delisted from a national securities exchange or no longer being quoted in an inter-dealer quotation system of a registered national securities association, (viii) a series of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, or (ix) any action similar to any of those described above. However, the Reporting Person, in her capacity as a Director may, from time to time, become aware of, initiate, and/or be involved in discussions that relate to the transactions described in this Item 4 and thus retains her right to modify her plans with respect to the transactions described in this Item 4 to acquire or dispose of securities of the Issuer and to formulate plans and proposals that could result in the occurrence of any such events, subject to applicable laws and regulations.

Item 5. Interest in Securities of the Issuer

     a) The Reporting Person beneficially owns 547,858 shares of the Issuer’s Series B common stock, representing approximately 22.3% of the shares of the Issuer’s Series B common stock treated as being outstanding as of December 31, 2008. The 547,858 shares of the Issuer’s Series B common stock beneficially owned by the Reporting Person include 13,609 Series B shares subject to options that are presently exercisable or that become exercisable within 60 days.

     b) As of the date of this Schedule 13D, the Reporting Person has the sole power to vote and sole dispositive power over 547,858 shares of the Issuer’s Series B common stock, which represents approximately 22.3% of the shares of the Issuer’s Series B common stock treated as being outstanding as of December 31, 2008.

     c) Except as disclosed in Item 4, the Reporting Person has not effected any transaction involving shares of Common Stock of the Issuer during the past 60 days.

     d) Not Applicable.

     e) Not Applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

     To the best knowledge of the Reporting Person, except as disclosed in this Schedule 13D and its amendments, there are as of the date of this Schedule 13D, no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Person and any person with respect to any securities of the Issuer, including, but not limited to, transfer or voting of any of the securities of the Issuer, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss or the giving or withholding of proxies, or a pledge or contingency the occurrence of which would give another person voting power or investment power over the Common Stock of the Issuer.

Item 7. Material to be Filed as Exhibits

     Not Applicable.

SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.